Marshall Wace’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Marshall Wace’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-170,500	Closed	-$14.9M	–	1205
2016 Q2	$14.9M	Buy	+170,500	New	+$14.4M	0.13%	184

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Marshall Wace's GWPH Position: Q2 2021 in Review

Marshall Wace sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 85,060 shares — an estimated $18.4M sold.

Marshall Wace first reported a position in GWPH in Q4 2015 and held it in 9 quarters. The position peaked at $18.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Marshall Wace reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 85,060 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $18.4M.
Marshall Wace first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 9 quarters.
Marshall Wace's GW Pharmaceuticals Plc American Depositary Shares position peaked at $18.4M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.